| REIMBUSEMENT UPDATE |
|
|
|
FEATURE STORIES
|
|
ACTION ALERT: FY19 Inpatient Prospective Payment System (IPPS) Proposed Rule
The Centers for Medicare and Medicaid Services (CMS) issued the FY19 Inpatient Prospective Payment System (IPPS) proposed rule on April 24. The IPPS proposed rule spells out future payment policies and reimbursement for inpatient treatments, including autologous and allogeneic hematopoietic cell transplant (HCT). Although we have continued advocacy efforts at both the Agency and with the U.S. Congress around HR 4215, we are disappointed to report that the proposed rule did not address allogeneic HCT cell acquisition payment policy. Lack of attention to this issue will threaten Medicare patient access to transplant. Learn more about the IPPS proposed rule, proposed reimbursement and context around HR 4215.
|
| |
|
NMDP Advocacy Secures Increased Funding for the C.W. Bill Young Cell Transplantation Program and National Cord Blood Inventory
NMDP advocacy efforts were successful in securing an additional $2 million in funding for the C.W. Bill Young Cell Transplantation Program and $3 million for the National Cord Blood Inventory (NCBI). This additional funding will allow us to help more patients access life-saving cellular therapy, improve our donor search strategy, conduct innovative research to inform practice and improve outcomes, and provide more financial assistance to our vulnerable patient population.
Read the full story
|
| |
|
NMS Final Rule on Essential Health Benefits for Participating Individual Exchange Plans
The Centers for Medicare and Medicaid Services (CMS) issued a final rule in early April that will allow states to set their 2020 Essential Health Benefits (EHB) benchmarks based on any other state's 2017 EHB-benchmark plan. In addition, this rule will allow states to replace any of the ten required EHBs in their current 2017-benchmark plan, mandated under current Affordable Care Act (ACA) law, with the same category of benefits from a separate state's 2017 EHB-benchmark plan.
Read the HHS Notice >
|
| |
|
Meet Roman
Roman has a rare disease called Shwachman-Diamond syndrome. As a result of the disease, Roman has a weakened immune system—and something as common as a cold could be deadly. A blood stem cell transplant from a genetically matched donor is his only hope to fight his life-threatening disease.
Learn about Roman's journey to find a match
|
|
CONFERENCES & EDUCATION
|
|
Where can you find us next?
Susan Leppke and Alicia Silver (Public and Payer Policy) will be attending the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, June 1 - 4.
Rachel Glissmann (Pubic and Payer Policy) and Scott Kerwin (Patient and Health Professional Services) will be exhibiting at the 2018 CMSA Annual Conference & Expo in Chicago, June 19-23. If you are attending, please stop by our booth (#5)!
|
|
|
|
Education Opportunities
NOW AVAILABLE: Recorded Webinar - Optimal Coverage and Reporting of HCT for 2018
Access the webinar recording of "Optimal Coverage and Reporting of HCT for 2018" presented by NMDP's Public and Payer Policy Team with experts in Medicare cost reporting, HCT coding and billing, and Medicare coverage.
Watch it here >
|
| |
|
Forward to a Friend
Please feel free to forward this email to others who would benefit from this information. If this email was forwarded to you, we invite you to subscribe.
If you have any questions or need additional information, please contact the Payer Policy Team at payerpolicy@nmdp.org.
All of our resources are available on our website: Network.BeTheMatchClinical.org/Reimbursement
|
